| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0004 |